Detalles de la búsqueda
1.
Immunostimulatory oncolytic activity of coxsackievirus A11 in human malignant pleural mesothelioma.
Cancer Sci
; 114(3): 1095-1107, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369966
2.
MicroRNA-326 negatively regulates CD155 expression in lung adenocarcinoma.
Cancer Sci
; 114(10): 4101-4113, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37565582
3.
YAP mediates resistance to EGF-induced apoptosis in EGFR-mutated non-small cell lung cancer cells.
Biochem Biophys Res Commun
; 681: 120-126, 2023 Nov 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774569
4.
Immune-checkpoint profiles for T cells in bronchoalveolar lavage fluid of patients with immune-checkpoint inhibitor-related interstitial lung disease.
Int Immunol
; 32(8): 547-557, 2020 07 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32253426
5.
Paired genetic analysis by next-generation sequencing of lung cancer and associated idiopathic pulmonary fibrosis.
Cancer Sci
; 111(7): 2482-2487, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32426915
6.
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
Cancer
; 126(1): 219-227, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31503343
7.
Survival Analysis for Patients with ALK Rearrangement-Positive Non-Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
Oncologist
; 25(4): 306-e618, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32297438
8.
Genetic Profiling of Non-Small Cell Lung Cancer at Development of Resistance to First- or Second-Generation EGFR-TKIs by CAPP-Seq Analysis of Circulating Tumor DNA.
Oncologist
; 24(8): 1022-1026, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023862
9.
Exploration of resistance mechanisms for epidermal growth factor receptor-tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next-generation sequencing.
Cancer Sci
; 109(12): 3921-3933, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30289575
10.
Prediction of Therapeutic Effect of Chemotherapy for NSCLC Using Dual-Input Perfusion CT Analysis: Comparison among Bevacizumab Treatment, Two-Agent Platinum-based Therapy without Bevacizumab, and Other Non-Bevacizumab Treatment Groups.
Radiology
; 286(2): 685-695, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29059037
11.
Phase I study of salazosulfapyridine in combination with cisplatin and pemetrexed for advanced non-small-cell lung cancer.
Cancer Sci
; 108(9): 1843-1849, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667792
12.
Severe acute interstitial lung disease in a patient with anaplastic lymphoma kinase rearrangement-positive non-small cell lung cancer treated with alectinib.
Invest New Drugs
; 33(5): 1148-50, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26334220
13.
Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement.
Invest New Drugs
; 33(2): 510-2, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433426
14.
Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer.
Biol Pharm Bull
; 38(8): 1192-8, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26235582
15.
Osimertinib readministration for central nervous system metastases in non-small cell lung cancer positive for EGFR activating mutations.
Respir Investig
; 62(3): 334-338, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38412569
16.
TP53 gain-of-function mutations promote osimertinib resistance via TNF-α-NF-κB signaling in EGFR-mutated lung cancer.
NPJ Precis Oncol
; 8(1): 60, 2024 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38431700
17.
Tracheomediastinal fistula induced by concurrent chemoradiotherapy in small cell lung cancer: A case report and literature review.
Thorac Cancer
; 15(13): 1106-1111, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528720
18.
Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.
Clin Lung Cancer
; 25(4): 389-394, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38413246
19.
Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer.
JCO Precis Oncol
; 8: e2300681, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38748981
20.
Clinical outcomes in patients with non-small cell lung cancer harboring EGFR Exon20 in-frame insertions in the near-loop and far-loop: Results from LC-SCRUM-Asia.
Lung Cancer
; 191: 107798, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38669727